pancreatin drug combination 7-diethoxyisoquinoline hydrochloride 5,7-dichloro-8-quinolinol 1-((3,4-diethoxyphenyl)methyl)-6

contains 5,7-dichloro-8-hydroxyquinoline, pancreatin & ethylpapaverine

Also Known As:

1-((3,4-diethoxyphenyl)methyl)-6, 5,7-dichloro-8-quinolinol, 7-diethoxyisoquinoline hydrochloride, pancreatin drug combination; 1-((3,4-diethoxyphenyl)methyl)-6, 5,7-dichloro-8-quinolinol - 7-diethoxyisoquinoline hydrochloride - pancreatin; Hylacombun; Hylakombun; Pancreatin, mixt. with 5,7-dichloro-8-quinolinol and 1-((3,4-diethoxyphenyl)methyl)-6,7-diethoxyisoquinoline hydrochloride

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Dysbiosis 04/20/1973 - "[Treatment of intestinal dysbiosis using Hylakombun]." 02/04/1972 - "[Treatment of intestinal dysbiosis with Hylakombun]."
2.	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/01/1996 - "[Hylacombun in inflammatory bowel diseases]."
3.	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 07/10/1971 - "[Clinical study on HK 2 (Hylakombun) in gastrointestinal diseases]."